Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
Abstract Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found...
Guardado en:
Autores principales: | Yuek Ling Chai, Joyce R. Chong, Ainiah R. Raquib, Xin Xu, Saima Hilal, Narayanaswamy Venketasubramanian, Boon Yeow Tan, Alan P. Kumar, Gautam Sethi, Christopher P. Chen, Mitchell K. P. Lai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1b12e90137f45e5a30c6c0e5d07ecd7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation
por: Petra Popovics, et al.
Publicado: (2021) -
Stroke Care in Pakistan
por: Anjum Farooq, et al.
Publicado: (2021) -
Hairy/enhancer of Split Homologue-1 Suppresses Vascular Endothelial Growth Factor-induced Angiogenesis via Downregulation of Osteopontin Expression
por: Xing-Xing Yao, et al.
Publicado: (2017) -
Plasma and follicular fluid osteopontin levels during ovarian cycle and their correlation with follicular fluid vascular endothelial growth factor levels
por: Yoshimitsu Kuwabara, et al.
Publicado: (2021) -
A Pivotal Role for AP-1-Mediated Osteopontin Expression in the Increased Migration of Vascular Smooth Muscle Cells Stimulated With HMGB1
por: Eun Yeong Jeon, et al.
Publicado: (2021)